The language of prostate cancer treatments and implications for informed decision making by patients

European Journal of Cancer Care

Volumn 21, Issue 6, 2012, Pages 766-775

  Rot, I ^a   Ogah, I ^a   Wassersug, R J ^b,c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c LA TROBE UNIVERSITY   (Australia)

Author keywords

Castration; Decision; Hormone therapy; Language; Prostate cancer

Indexed keywords

EID: 84867910829     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2012.01359.x     Document Type: Article

References (46)

1. Aucoin M. & Wassersug R.J. (2006) The sexuality and social performance of androgen-deprived (castrated) men throughout history: implications for modern day cancer patients. Social Science and Medicine 63, 3162-3173.
2. Berry D.L., Ellis W.J., Woods N.F., Schwien C., Mullen K.H. & Yang C. (2003) Treatment decision-making by men with localized prostate cancer: the influence of personal factors. Urologic Oncology 21, 93-100.
3. Bickell N.A., Weidmann J., Fei K., Lin J.J. & Leventhal H. (2009) Underuse of breast cancer adjuvant treatment: patient knowledge, beliefs, and medical mistrust. Journal of Clinical Oncology 27, 5160-5167.
4. Bungay H. & Cappello R. (2009) 'As long as the doctors know what they are doing': trust or ambivalence about patient information among elderly men with prostate cancer? European Journal of Cancer Care 18, 470-476.
5. Chapman K., Abraham C., Jenkins V. & Fallowfield L. (2003) Lay understanding of terms used in cancer consultations. Psycho-Oncology 12, 557-566.
6. Chapple A. & Ziebland S. (2002) Prostate cancer: embodied experience and perceptions of masculinity. Sociology of Health and Illness 24, 820-841.
7. Charmaz K. (1994) Identity dilemmas of chronically ill men. The Sociological Quarterly 35, 269-288.
8. Chen J.Y., Diamant A.L., Thind A. & Maly R.C. (2008) Determinants of breast cancer knowledge among newly diagnosed, low-income, medically underserved women with breast cancer. Cancer 112, 1153-1161.
9. Courtenay W.H. (2000) Constructions of masculinity and their influence on men's well-being: a theory of gender and health. Social Science and Medicine 50, 1385-1401.
10. Cushman M.A., Phillips J.L. & Wassersug R.J. (2010) The language of emasculation: implications for cancer patients. International Journal of Men's Health 9, 3-25.
11. Davison B.J., Oliffe J.L., Pickles T. & Mroz L. (2009) Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer. Oncology Nursing Forum 36, 89-96.
12. Elliott S., Latini D.M., Walker M., Wassersug R.J., Robinson J.W. & the ADT Survivorship Working Group (2010) Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life. The Journal of Sexual Medicine 7, 2996-3010.
13. Fagerlin A., Lakhani I., Lantz P.M., Janz N.K., Morrow M., Schwartz K., Deapen D., Salem B., Liu L. & Katz S.J. (2006) An informed decision? Breast cancer patients and their knowledge about treatment. Patient Education and Counseling 64, 303-312.
14. Fergus K.D., Gray R.E., Fitch M.I., Labrecque M. & Phillips C. (2002a) Active consideration: conceptualizing patient-provided support for spouse caregivers in the context of prostate cancer. Qualitative Health Research 12, 492-514.
15. Fergus K.D., Gray R.E. & Fitch M.I. (2002b) Sexual dysfunction and the preservation of manhood: experiences of men with prostate cancer. Journal of Health Psychology 7, 301-316.
16. Ferlay J., Autier P., Boniol M., Heanue M., Colombet H. & Boyle P. (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Annals of Oncology 18, 581-592.
17. Forbat L., White I., Marshall-Lucette S. & Kelly D. (2011) Discussing the sexual consequences of treatment in radiotherapy and urology consultations with couples affected by prostate cancer. BJU International 109, 98-103.
18. Gray R.E., Fitch M.I., Phillips C., Labrecque M. & Klotz L. (1999) Presurgery experiences of prostate cancer patients and their spouses. Cancer Practice 7, 130-135.
19. Gray R.E., Fitch M.I., Phillips C., Labrecque M. & Fergus K. (2000) To tell or not to tell: patterns of disclosure among men with prostate cancer. Psycho-Oncology 9, 273-282.
20. Green H., Wells D. & Laakso L. (2011) Coping in men with prostate cancer and their partners: a quantitative and qualitative study. European Journal of Cancer Care 20, 237-247.
21. Harle L.K., Maggio M., Shahani S., Braga-Basaria M. & Basaria S. (2006) Endocrine complications of androgen-deprivation therapy in men with prostate cancer. Clinical Advances in Hematology and Oncology 4, 687-696.
22. Heyman E.N. & Rosner T.T. (1996) Prostate cancer: an intimate view from patients and wives. Urologic Nursing 16, 37-44.
23. Higano C. (2006) Androgen deprivation therapy: monitoring and managing the complications. Hematology/Oncology Clinics of North America 20, 909-923.
24. Hussain S., Gunnell D., Donovan J., Mcphail S., Hamdy F., Neal D., Albertsen P., Verne J., Stephens P., Trotter C. & Martin R.M. (2008) Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004. BJU International 101, 547-555.
25. Isbarn H., Boccon-Gibod L., Carroll P.R., Montorsi F., Schulman C., Smith M.R., Sternberg C.N. & Studer U.E. (2009) Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks. European Urology 55, 62-75.
26. Ismail M., Ferroni M. & Gomella L.G. (2011) Androgen suppression strategies for prostate cancer: is there an ideal approach? Current Urology Reports 12, 188-196.
27. Jenkins V., Fallowfield L. & Saul J. (2001) Information needs of patients with cancer: results from a large study in UK cancer centres. British Journal of Cancer 84, 48-51.
28. Kelly D. (2009) Changed men: the impact of prostate cancer. Qualitative Health Research 19, 151-164.
29. Lin G.A., Aaronson D.S., Knight S.J., Carroll P.R. & Dudley R.A. (2009) Patient decision aids for prostate cancer treatment: a systematic review of the literature. CA: A Cancer Journal for Clinicians 59, 379-390.
30. Nanton V., Osborne D. & Dale J. (2010) Maintaining control over illness: a model of partner activity in prostate cancer. European Journal of Cancer Care 19, 329-339.
31. Navon L. & Morag A. (2003) Advanced prostate cancer patients' ways of coping with the hormonal therapy's effect on body, sexuality and spousal ties. Qualitative Health Research 13, 1378-1392.
32. Potosky A.L., Knopf K., Clegg L.X., Albertsen P.C., Stanford J.L., Hamilton A.S., Gilliland A.S., Elay J.W., Stephenson R.A. & Hoffman R.M. (2001) Quality of life outcomes after primary androgen deprivation therapy: results from the prostate cancer outcomes study. Journal of Clinical Oncology 19, 3750-3757.
33. Rot I., Ogah I. & Wassersug R.J. (2012) Knowledge of reproductive system cancers, their treatments and side effects. Journal of Cancer Education. Epub ahead of print doi: 10.1007/s13187-012-0344-1.
34. Sajid S., Mohile S.G., Szmulewitz R., Posadas E. & Dale W. (2011) Individualized decision-making for older men with prostate cancer: balancing cancer control with treatment consequences across the clinical spectrum. Seminars in Oncology 38, 309-325.
35. Seidler V. (1998) Masculinity, violence and emotional life. In: Emotions in Social Life. Critical Themes and Contemporary Issues (eds Bendelow G. & Williams S.), pp. 191-207. Routledge, London, UK.
36. Shahinian V.B., Kuo Y.F., Freeman J.L. & Goodwin J.S. (2006) Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist. Journal of the National Cancer Institute 98, 839-845.
37. Shahinian V.B., Kuo Y.F. & Gilbert S.M. (2010) Reimbursement policy and androgen-deprivation therapy for prostate cancer. The New England Journal of Medicine 363, 1822-1832.
38. Smith M.R. (2007) Androgen deprivation therapy for prostate cancer: new concepts and concerns. Current Opinion in Endocrinology, Diabetes, and Obesity 3, 247-254.
39. Sprenkle P.C. & Fisch H. (2007) Pathologic effects of testosterone deprivation. Current Opinion in Urology 7, 424-430.
40. Steginga S.K., Occhipinti S., Gardiner R.A., Yaxley J. & Heathcote P. (2002) Making decisions about treatment for localized prostate cancer. BJU International 89, 255-260.
41. The National Cancer Institute (2010) SEER Stat Fact Sheets: All Sites. Available at: http://seer.cancer.gov/statfacts/html/all.html (accessed 15 May 2011).
42. Walker L.M., Tran S., Wassersug R.J., Thomas B. & Robinson J.W. (2012) Patients and partners lack knowledge of androgen deprivation therapy side effects. Urologic Oncology. Epub ahead of print. doi: 10.1016/j.urolonc.2011.12.015.
43. Wassersug R.J. & Oliffe J.L. (2009) The social context for psychological distress from iatrogenic gynecomastia with suggestions for its management. The Journal of Sexual Medicine 6, 989-1000.
44. Whelan T., Levine M., Willan A., Gafno A., Sanders K., Mirsky D., Chambers S., O'brien M.A., Reid S. & Dubois S. (2004) Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery. JAMA: the Journal of the American Medical Association 292, 435-441.
45. Wittmann D., He C., Coelho M., Hollenbeck B., Montie J.E. & Wood D.P., Jr (2011) Patient preoperative expectations of urinary, bowel, hormonal and sexual functioning do not match actual outcomes 1 year after radical prostatectomy. The Journal of Urology 186, 494-499.
46. Zeliadt S.B., Penson D.F., Moinpour C.M., Blough D.K., Fedorenko C.R. & Hall I.J. (2011) Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer. BJU International 108, 851-857.